HEUKING Advised Berlin-based HealthTech Start-Up Hellomed on its Seed II Financing Round
HEUKING advised hellomed Group GmbH, a Berlin-based HealthTech start-up, in connection with its Seed II financing round,
HEUKING Advised Berlin-based HealthTech Start-Up Hellomed on its Seed II Financing Round
HEUKING advised hellomed Group GmbH, a Berlin-based HealthTech start-up, in connection with its Seed II financing round, raising approximately €6 million. The proceeds from the funding will be used to expand hellomed’s digital medication management solution, hellomedOS, aimed at preventing medication errors in outpatient and inpatient care and reducing the workload of nursing staff.
Hellomed Group GmbH, based in Berlin, was founded by Enrico Bernardo, Felix Morawski, and Tim Bogdan and is developing hellomedOS, a software solution for quality-assured medication management in outpatient and inpatient care. With hellomedOS, hellomed is digitizing particularly error-prone, system-relevant processes between care companies, pharmacies, patients, and relatives. The aim is to increase medication safety, noticeably reduce the workload on nursing staff, and reduce avoidable follow-up costs in the healthcare system.
The HEUKING team was led by Dr. Patrick Müller (Partner/ Lead/ Venture Capital, Düsseldorf), Ilona Schütz (Senior Associate, Düsseldorf, Cologne), Caroline Frohnwieser (Senior Associate/ Venture Capital, Hamburg) and Laura Jochem (Associate/ Venture Capital, Norwich, Düsseldorf).
If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.